Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,357,979 papers from all fields of science
Search
Sign In
Create Free Account
brentuximab vedotin 50 MG Injection [Adcetris]
Known as:
Adcetris 50 MG Injection
, Brentuximab Vedotin 50 mg in 10.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ADCETRIS]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Adcetris
Injection
Polysorbate 80
TREHALOSE DIHYDRATE
Expand
Broader (1)
brentuximab vedotin Injection [Adcetris]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
L. McGahan
2019
Corpus ID: 201176033
Several peripheral T-cell lymphomas (PTCL) express the tumour necrosis factor (TNF) receptor CD30, conferring cell survival and…
Expand
2017
2017
Enzyme-Based Strategies to Generate Site-Specifically Conjugated Antibody Drug Conjugates
R. Beerli
,
U. Grawunder
2017
Corpus ID: 168672031
Antibody Drug Conjugates (ADCs) exploit the specificity of monoclonal antibodies for the targeting of highly potent small…
Expand
2014
2014
Abstract 2514: Towards homogenous adcs: A new site-specific antibody conjugation using bacterial transglutaminase (btg-adc)
F. Lhospice
,
Delphine Brégeon
,
+6 authors
F. Romagné
2014
Corpus ID: 72817193
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Purpose : Bacterial Transglutaminase (BTG) allows coupling…
Expand
2013
2013
Rezidivierte Lymphome zielgerichtet mit Brentuximab Vedotin behandeln
Pm
Info Onkologie
2013
Corpus ID: 57103621
Mit dem Antikörper-Wirkstoff-Konjugat Brentuximab Vedotin (Adcetris®) von Takeda steht seit zwanzig Jahren erstmals wieder eine…
Expand
Review
2012
Review
2012
Brentuximab (Adcetris®) for the treatment of relapsed Hodgkin's lymphoma (HL) or relapsed systemic anaplastic large cell lymphoma (sALCL)
K. Hintringer
2012
Corpus ID: 56496262
Brentuximab vedotin is an antibody-drug conjugate (ADC) directed against the tumour necrosis factor (TNF) receptor CD30 which is…
Expand
2012
2012
mRCC: Neue Chance in der zweiten Linie
F. Klein
Im Focus Onkologie
2012
Corpus ID: 183887787
2011
2011
Patient Management With ADCETRIS™: An Advanced Practice Oncology Nurse Roundtable Discussion
A. Copeland
2011
Corpus ID: 78856381
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE